A Mayo Clinic analysis of two decades of autopsy results shows a long-term decline in the prevalence of coronary disease has ended and the disease may be on the upswing. The findings appear in today’s issue of Archives of Internal Medicine.
“If this is borne out by future analyses, it will be the first change in the trend since the decline in heart disease death rates began in the mid-1960s,” says Cynthia Leibson, Ph.D., Mayo Clinic epidemiologist and senior author of the study. In their article, the researchers recognize the corresponding rise in national obesity and diabetes rates in roughly the same period but say that further research would be needed to establish any connection.
Researchers from Mayo Clinic and from the University of British Columbia used death certificate data to identify all Olmsted County, Minn., residents who died between 1981 and 2004. Olmsted County, long the focus of detailed medical record reporting by Mayo Clinic and the Rochester Epidemiology Project, has been a reliable snapshot of national disease trends. The study was limited to persons who died at ages 16 through 64 from nonnatural causes, a subset for which the autopsy rate is exceptionally high.
Review of the pathology reports for these 515 individuals revealed that 425 (82 percent) had a degree of coronary artery atherosclerosis assessed at autopsy. Of that group, 83 percent showed signs of coronary artery disease and just over 8 percent had a high level of the disease. The analysis over the entire 23-year period revealed declines for three distinct categories: high level, any level, and average degree of coronary artery disease. However, the declines in the degree of disease stopped after 1995 and may have actually headed upward -- after the year 2000.
Source: Mayo Clinic
Related stories:
Mayo Clinic estimates new, tiny, super-sensitive probe could cut colon polyp removal in half
Based on results of a landmark study, researchers at Mayo Clinic's Florida campus see a future in which virtual biopsies will eliminate the need to remove colon polyps that are not cancerous or will not morph into the disease.
Mayo researchers explore issues related to multiple myeloma treatment
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Unfortunately, some of the most effective therapies also have toxic side effects that can pose serious health risks and reduce quality of life. In the October issue of
Mayo Clinic Proceedings, two articles authored by Mayo researchers address the issue of how to balance the risks and benefits associated with MM treatments.
Neurotransmitter defect may trigger autoimmune disease
A potentially blinding neurological disorder, often confused with multiple sclerosis (MS), has now become a little less mysterious. A new study by researchers at the Mayo Clinic in Rochester, Minnesota, may have uncovered the cause of Devic's disease. Their new study, which will appear online on October 6th in the
Journal of Experimental Medicine, could result in new treatment options for this devastating disease.
Jump seen in staph-linked flu deaths in kids
(AP) -- More children have died from flu because they also had staph infections, according to a new government report that urges parents to have their kids get the flu shot.
Research suggests doctors should consider kidney-sparing surgery
A study of almost 1,500 kidney cancer patients treated at Memorial Sloan Kettering Cancer Center suggests that surgery to spare as much kidney tissue as possible may improve overall survival in patients who also have reduced kidney function at the time their cancer is diagnosed. The finding is significant because both kidney cancer and decreased kidney function appear to be increasing.
No longer depressed, or on meds
Henry Quant was just 5 years old and bedridden with chronic fevers when he began taking pills for anxiety and depression. His mother knew that the drugs helped, but they made her nervous.
Stem cell regeneration repairs congenital heart defect
Mayo Clinic investigators have demonstrated that stem cells can be used to regenerate heart tissue to treat dilated cardiomyopathy, a congenital defect. Publication of the discovery was expedited by the editors of
Stem Cells and appeared online in the "express" section of the journal's Web site at
http://stemcells.alphamedpress.org/.
Mayo Clinic chest surgeons propose measures for indicating quality of lung surgery
Even though 30,000 patients in the United States undergo lung surgery each year, no standard criteria exist to measure the quality of their care. In the current issue of
The Annals of Thoracic Surgery, Mayo Clinic surgeons have proposed a system of lung surgery quality indicators for surgeons and the public as a method to demonstrate best practices for obtaining positive patient outcomes.